Is There a Genetic Test for Familial APS? What to Know
At a Glance
There is no validated DNA test that can diagnose familial antiphospholipid syndrome. APS is a multifactorial autoimmune condition assessed through clinical history and repeat antiphospholipid antibody testing; selected families may be evaluated for separate inherited clotting disorders.
The short answer is no. There is currently no validated clinical genetic test (DNA test) that can diagnose, predict, or rule out familial antiphospholipid syndrome (APS) [1][2].
While it is natural to want a simple cheek swab or blood test to tell you if you have inherited a condition that runs in your family, APS does not work like a traditional genetic disease. Diagnosis relies on your personal medical history and specific blood tests that check for autoantibodies, rather than looking for a mutated gene [1][2].
Why Isn’t There a DNA Test for APS?
In single-gene disorders like cystic fibrosis or Huntington’s disease, mutations in a specific gene cause the disease. These conditions can often be tested for directly with DNA.
APS, on the other hand, is a complex autoimmune condition [3]. It is considered multifactorial, meaning it develops from a combination of minor genetic variations and environmental triggers (such as infections) [3]. While families can share these genetic predispositions—and rare cases of APS in identical twins have been reported [4]—there is no single predictable inheritance pattern or “APS gene” to test for.
Researchers have identified certain genetic markers that are more common in people with APS. These include variations in the HLA genes (which help regulate the immune system), as well as research associations like STAT4 and C1D [3][5]. However, these are merely population-level susceptibility markers [3]. They mean someone might have a slightly higher baseline risk of developing an autoimmune disease, but they cannot be used clinically to diagnose APS [3].
How is Familial APS Actually Evaluated?
Because genetics cannot provide a diagnosis, doctors evaluate you for APS based on two areas: your clinical history and whether clinically significant antiphospholipid antibodies persist in your blood [2][6]. A family history of APS is an important clue, but it cannot substitute for your own symptoms and test results [6].
Clinicians generally use classification frameworks to guide diagnosis, looking for:
- A clinical event: A history of blood clots (venous, arterial, or small-vessel thrombosis) or specific pregnancy complications. The pregnancy criteria usually involve: three or more consecutive unexplained miscarriages before 10 weeks, one unexplained loss of a normal fetus at or after 10 weeks, or delivery before 34 weeks due to severe pre-eclampsia or placental insufficiency [2][6].
- Positive antiphospholipid (aPL) antibodies: Blood tests must show the presence of specific autoantibodies at moderate to high levels. The three primary tests are lupus anticoagulant, anticardiolipin, and anti-β2-glycoprotein I [1][7].
- Note on Lupus Anticoagulant: This name is very confusing. It does not mean you have lupus, and despite the word “anticoagulant” (blood thinner), having this antibody actually increases your risk of blood clots.
Because antibody levels can temporarily spike due to common infections, a single positive test is not enough. The positive result must be confirmed by a second blood test taken at least 12 weeks later [8].
Important Medication Warning: Testing for lupus anticoagulant requires special care, as being on blood thinners (like warfarin, heparin, or direct oral anticoagulants) can cause false-positive or false-negative results [8][9]. Never stop or alter your blood thinners to get tested without direct medical supervision. Coordinate the timing with your prescribing doctor and the laboratory.
Should Asymptomatic Family Members Be Tested?
Routine screening of healthy relatives is generally not recommended simply because of a family history [10]. A positive antibody test in a healthy person can cause unnecessary anxiety and does not, by itself, justify starting preventive blood thinners [10][11].
If you test positive for aPL antibodies without having had a clot, your doctor will look at your overall risk profile. Risk varies substantially: people who are “triple positive” (positive for all three antibodies) or who have persistent lupus anticoagulant are at a higher risk than those with a single antibody [10][11]. Other factors like smoking, estrogen use, systemic lupus, and immobility also heavily influence clot risk.
When Are Genetic Consultations or Hematology Referrals Useful?
While there is no DNA test for APS itself, a referral to a hematologist (blood specialist) or a thrombosis clinic can be highly valuable for families with a strong history of blood clots [12].
APS is an acquired autoimmune disorder [12]. However, there are completely separate inherited thrombophilias (clotting disorders) that are caused by direct genetic mutations. Examples include Factor V Leiden and the prothrombin G20210A mutation, which are tested via DNA, as well as antithrombin deficiency, which is typically initially assessed with functional blood tests [12][5].
A doctor may consider selective testing for these inherited conditions if:
- You or your relatives have had unprovoked blood clots at a young age (often considered under 50, though this is a guideline, not a strict rule) [6].
- Blood clots keep happening despite treatment.
- Multiple family members have a history of clotting [12].
- The results would actually change your medical management or preventative care [12].
| What the Test Looks For | APS Antibody Testing | Inherited Thrombophilia Testing (e.g., Factor V Leiden) |
|---|---|---|
| What it measures | Autoantibodies (immune system proteins) in the blood | Specific genetic mutations (DNA) or functional protein deficiencies |
| What it diagnoses | Acquired autoimmune clotting risk (APS) | Inherited genetic clotting disorders |
| How it’s used | Requires two tests 12 weeks apart | Usually a one-time genetic or functional test |
Safety Warning: When to Seek Immediate Care
Because a family history of APS or other clotting disorders increases your risk for blood clots, it is important to know the warning signs. Seek emergency medical attention immediately if you experience sudden shortness of breath, unexplained chest pain, coughing up blood, swelling or pain in one leg or arm, or sudden neurological changes (like weakness on one side of the face or body, or difficulty speaking).
Common questions in this guide
Can antiphospholipid syndrome run in families?
Can a DNA test diagnose or rule out familial APS?
Which blood tests are used to evaluate APS?
Should I have APS antibody testing just because a relative has APS?
What genetic clotting tests might be considered in a family with many blood clots?
Can blood thinners change the results of APS testing?
What clot symptoms require emergency care if I have a family history of APS?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.If my family has a history of blood clots, could this be caused by an inherited thrombophilia (like Factor V Leiden) instead of, or in addition to, APS?
- 2.Based on my family history and my own medical background, do you recommend I be tested for antiphospholipid antibodies, or is routine screening not necessary for me?
- 3.If I had a positive antibody test in the past, do I need repeat testing to confirm persistence, and would any later result change my care?
- 4.What specific symptoms of blood clots should I watch out for, and when should I seek emergency care?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances.
Vandevelde A, Devreese KMJ
Journal of clinical medicine 2022; (11(8)) doi:10.3390/jcm11082164.
PMID: 35456258 - 2
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
Barbhaiya M, Zuily S, Naden R, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(10)):1687-1702 doi:10.1002/art.42624.
PMID: 37635643 - 3
Genetics of Antiphospholipid Syndrome.
Ortiz-Fernández L, Sawalha AH
Current rheumatology reports 2019; (21(12)):65 doi:10.1007/s11926-019-0869-y.
PMID: 31807905 - 4
Double trouble: myocardial infarction with non-obstructive coronary arteries as a presentation of Hughes syndrome in monozygotic twins.
Djokovic A, Stojanovich L, Stanisavljevic N, et al.
Lupus 2020; (29(5)):505-508 doi:10.1177/0961203320906267.
PMID: 32041501 - 5
Genetic aspects of the antiphospholipid syndrome: An update.
Sebastiani GD, Iuliano A, Cantarini L, Galeazzi M
Autoimmunity reviews 2016; (15(5)):433-9.
PMID: 26804759 - 6
Antiphospholipid syndrome.
Petri M
Translational research : the journal of laboratory and clinical medicine 2020; (225()):70-81 doi:10.1016/j.trsl.2020.04.006.
PMID: 32413497 - 7
Antiphospholipid Antibody Testing for Anti-cardiolipin and Anti-β2 Glycoprotein I Antibodies Using Chemiluminescence-Based Panels.
Favaloro EJ, Mohammed S, Vong R, Pasalic L
Methods in molecular biology (Clifton, N.J.) 2023; (2663()):297-314 doi:10.1007/978-1-0716-3175-1_19.
PMID: 37204719 - 8
[Laboratory diagnosis of antiphospholipid syndrome: From criteria to practice].
Joste V, Dragon-Durey MA, Darnige L
La Revue de medecine interne 2018; (39(1)):34-41 doi:10.1016/j.revmed.2017.02.006.
PMID: 28302338 - 9
Testing for the lupus anticoagulant: the good, the bad, and the ugly.
Favaloro EJ, Pasalic L, Selby R
Research and practice in thrombosis and haemostasis 2024; (8(3)):102385 doi:10.1016/j.rpth.2024.102385.
PMID: 38623474 - 10
Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.
Chaturvedi S, McCrae KR
Current rheumatology reports 2017; (19(7)):43 doi:10.1007/s11926-017-0668-2.
PMID: 28711993 - 11
Antiphospholipid Syndrome: Thrombotic and Vascular Complications.
Windisch S, Ash JY, Frishman WH
Cardiology in review 2025; (33(2)):139-144 doi:10.1097/CRD.0000000000000590.
PMID: 37607079 - 12
Thrombophilia, risk factors and prevention.
Campello E, Spiezia L, Adamo A, Simioni P
Expert review of hematology 2019; (12(3)):147-158 doi:10.1080/17474086.2019.1583555.
PMID: 30773075
This page is for informational purposes only and does not constitute medical advice about familial APS or blood-clot risk. Do not stop or change blood thinners; discuss antibody or inherited-thrombophilia testing with your prescribing clinician or hematologist.
Get notified when new evidence is published on familial antiphospholipid syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.